×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| AARTI DRUGS LTD. | 5213.4 | 486.4 | 5209.6 | 5.33 | 4,521 | 24.0 |
| Dishman Carbogen Amcis Limited | 1002.8 | 26.7 | 628.6 | 0.17 | 4418 | 37.2 |
| INDRAPRASTHA MEDICAL CORP.LTD. | 3719.6 | 514.6 | 3650.6 | 5.61 | 4337 | 25.8 |
Aarti Drugs Limited, with Security Code 524348, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 696.4 | 591.6 | 577.5 | 538.2 | 559.5 | 493.0 | 543.1 | 514.5 | 623.0 | 521.0 |
| Expenses | 607.9 | 519.7 | 512.1 | 478.5 | 490.5 | 438.7 | 483.6 | 454.3 | 534.3 | 457.0 |
| Operating Profit | 88.5 | 71.9 | 65.4 | 59.7 | 69.1 | 54.2 | 59.5 | 60.3 | 88.7 | 64.0 |
| OPM % | 12.71% | 12.15% | 11.33% | 11.1% | 12.34% | 11% | 10.96% | 11.71% | 14.23% | 12.28% |
| Other Income | 0.9 | 0.7 | 0.7 | 1.7 | 1.1 | 0.1 | 0.4 | 11.4 | 1.7 | 0.4 |
| Interest | 8.4 | 7.8 | 7.6 | 6.8 | 8.1 | 7.5 | 7.2 | 7.6 | 7.5 | 6.8 |
| Depreciation | 11.7 | 11.8 | 11.8 | 11.8 | 12.3 | 11.7 | 11.9 | 12.0 | 12.2 | 12.3 |
| Profit before tax | 69.4 | 53.0 | 46.8 | 42.9 | 49.7 | 35.2 | 40.9 | 52.0 | 70.7 | 45.3 |
| Tax % | -23.4% | -25.5% | -26.2% | -26.2% | -27.3% | -23.5% | 25.7% | 25.9% | -12.9% | -7.5% |
| Net Profit | 53.2 | 39.5 | 34.6 | 31.6 | 36.1 | 26.9 | 30.4 | 38.5 | 61.5 | 48.6 |
| EPS in Rs | 5.74 | 4.27 | 3.75 | 3.44 | 3.93 | 2.93 | 3.33 | 4.22 | 0 | 5.33 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 664.0 | 742.4 | 661.1 | 641.5 | 605.9 | 620.0 | 555.3 | 598.3 | 556.6 | 676.8 |
| Expenses | 593.3 | 648.9 | 577.0 | 565.1 | 535.8 | 534.2 | 490.4 | 531.3 | 494.9 | 583.4 |
| Operating Profit | 70.7 | 93.5 | 84.1 | 76.5 | 70.1 | 85.8 | 65.0 | 67.1 | 61.7 | 93.4 |
| OPM % | 10.64% | 12.6% | 12.72% | 11.92% | 11.58% | 13.84% | 11.7% | 11.21% | 11.09% | 13.8% |
| Other Income | 1.0 | 0.9 | 0.6 | 0.7 | 1.7 | 1.1 | 1.1 | 1.5 | 11.9 | 1.9 |
| Interest | 9.4 | 8.6 | 8.5 | 8.3 | 7.6 | 9.1 | 8.7 | 8.9 | 9.1 | 9.2 |
| Depreciation | 12.6 | 12.5 | 12.6 | 12.6 | 12.7 | 13.6 | 13.4 | 13.7 | 13.8 | 14.9 |
| Profit before tax | 49.7 | 73.3 | 63.5 | 56.3 | 51.6 | 64.2 | 44.0 | 45.9 | 50.8 | 71.2 |
| Tax % | -26.2% | -23.3% | -24.5% | -29.6% | -28.8% | -26.3% | 24.4% | -23.8% | -26.9% | -11.7% |
| Net Profit | 36.7 | 56.2 | 48.0 | 39.6 | 36.7 | 47.3 | 33.3 | 35.0 | 37.1 | 62.8 |
| EPS in Rs | 3.96 | 6.07 | 5.18 | 4.29 | 3.99 | 5.15 | 3.62 | 3.83 | 4.06 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 4% |
| 1 Year: | -3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 4% |
| 3 Years: | -6% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 4% |
| 1 Year: | -3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|